Amsterdam, March 8, 2012 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces that it will publish the new journal of the Fellowship of Postgraduate Medicine (FPM), Health Policy and Technology.
In March FPM will launch the first issue of the cross-disciplinary journal focusing on past, present and future health policy and the role of technology in clinical and non-clinical national and international health environments. The journal will publish relevant, timely and accessible articles and commentaries to support policy-makers, health professionals, health technology providers, patient groups and academia interested in health policy and technology.
Topics covered will include: health technology, including drug discovery, diagnostics, medicines, devices, therapeutic delivery and eHealth systems; cross-national comparisons on health policy using evidence-based approaches; health technology assessment (HTA) methods and tools for evaluating the effectiveness of clinical and non-clinical health technologies; stakeholder engagement with health technologies (clinical and patient/citizen buy-in), Regulation and health economics (full aims & scope available online).
"We are delighted to be launching Health Policy and Technology in collaboration with Elsevier," Professor Donald Singer, President of the FPM and Chairman of the Advisory Board said of the launch. "Health Policy and Technology, will provide an additional way for FPM to continue to make important international contributions to the development of policy and practice within medicine and related disciplines, and is therefore an excellent complement to our first international publication, Postgraduate Medical Journal."
Professor Wendy L. Currie will lead the journal as Founding Editor-in-Chief, combining her expertise in academia, business consulting and non-profit sector, with her interests in global health. Introducing the journal, she stated, "The first issue of Health Policy and Technology will focus on Electronic Health Records (EHRs) in the 21st Century. It will include a paper on the pioneering new Centre for Health Technology Assessment of Devices and Diagnostics within the UK's National Institute for Health and Clinical Excellence (NICE). It will include a first series of interviews with international leaders in the field of health policy and technology, beginning with Sir Michael Rawlins, Chairman of NICE."
For more information about the new journal go to: http://www.healthpolicyandtechnology.org
About the FPM
The aim of the Fellowship of Postgraduate Medicine (FPM) is to promote international calibre excellence in postgraduate medical education through its publications, clinical and scientific meetings, and other activities. The FPM is a British medical charity that was founded at the end of World War I, when it pioneered development of post-graduate educational programs in all branches of medicine.
Its foundation was the result of a merger between the Fellowship of Medicine and the Postgraduate Medical Association, with Sir William Osler the first president of the new organization. The FPM is supported by Fellows with expertise in the practice of medicine, medical education and publishing, and research in medicine and related disciplines.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse® ScienceDirect®, SciVerse® Scopus®, Reaxys®, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal® suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Prof. Wendy Curry
Fellowship of Postgraduate Medicine (FPM)
+ 44 0207 636 6334
+ 31 20 485 3634
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.